[Federal Register: February 21, 2008 (Volume 73, Number 35)]
[Notices]               
[Page 9590-9591]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21fe08-91]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances; Notice of Registration

    By Notice dated November 6, 2007 and published in the Federal 
Register on November 16, 2007, (72 FR 64679), Formulation Technologies 
LLC., 11400 Burnet Road, Suite 4010, Austin, Texas 78758, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as an importer of Fentanyl (9801), a basic class of 
controlled substance listed in schedule II.
    The company plans to import the listed controlled substance for 
clinical trials, research, analytical purposes, and distribution to its 
customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Formulation Technologies LLC. to import the basic class 
of controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Formulation Technologies LLC. to ensure that the company's

[[Page 9591]]

registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with State and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 
1301.34, the above named company is granted registration as an importer 
of the basic class of controlled substance listed.

    Dated: February 12, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-3180 Filed 2-20-08; 8:45 am]

BILLING CODE 4410-09-P